Christina Takke

Fondateur chez

V-Bio Ventures BV

56 ans

42 relations

Health Technology

Finance

Consumer Services

Profil

Christina Takke is the founder and the Managing Partner of V-Bio Ventures BV, which was founded in 2015.
She is currently the Director at Confo Therapeutics NV, Precirix NV, Syndesi Therapeutics SA, and V-Bio Management 1 BV.
Dr. Takke was also a former Director at Roche Glycart AG, Amakem NV, and Pieris Pharmaceuticals, Inc. She served as an Independent Director at Pieris AG and was a Member-Supervisory Board at Polpharma Biologics Utrecht BV.
From 2013 to 2015, she was a Partner at Forbion Capital Partners Management Holding BV.
Dr. Takke also served as a Member-Supervisory Board at argenx SE.
She holds a graduate degree from Technische Universität Darmstadt and a doctorate degree from Universität zu Köln, which was conferred in 1998.

Postes actifs de Christina Takke

Sociétés	Poste	Début
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Fondateur	28/10/2015
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment	Directeur/Membre du Conseil	01/11/2018
Confo Therapeutics NV Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Directeur/Membre du Conseil	-
V-Bio Management 1 BV V-Bio Management 1 BV Financial ConglomeratesFinance Functions as an investment holding company	Directeur/Membre du Conseil	28/10/2015
Syndesi Therapeutics SA Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders	Directeur/Membre du Conseil	-

Tous les postes actifs de Christina Takke

Anciens postes connus de Christina Takke

Sociétés	Poste	Fin
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Private Equity Investor	31/12/2015
Roche Glycart AG Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products	Directeur/Membre du Conseil	-
PIERIS PHARMACEUTICALS	Directeur/Membre du Conseil	-
Amakem NV Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions	Directeur/Membre du Conseil	-
░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Voir l'expérience en détail de Christina Takke

Formation de Christina Takke

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christina Takke

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	14
Universität zu Köln Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technische Universität Darmstadt Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pieris AG Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology	Health Technology
Roche Glycart AG Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products	Health Technology
Polpharma Biologics Utrecht BV Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company	Commercial Services
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Finance
argenx SE argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases	Health Technology
Amakem NV Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions	Health Services
Pieris Pharmaceuticals, Inc. Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology	Health Technology
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Finance
Confo Therapeutics NV Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment	Health Technology
Syndesi Therapeutics SA Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders	Health Technology
V-Bio Management 1 BV V-Bio Management 1 BV Financial ConglomeratesFinance Functions as an investment holding company	Finance